PECAM1 and neoplasm: Tumor sections were subsequently stained with anti-CD31-DyLight 633 to visualize the microvascular endothelium and anti-PD-L1-DyLight 488 to label PD-L1 not reached by anti-PD-L1-DyLight 594 (Figure 3).